An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)

Eriko Suzuki (Tokyo-to, Japan), Eriko Suzuki, Takeda Yuichiro, Sugiyama Haruhito, Hojo Masayuki, Izumi Shinyu, Ikura Motokazu, Naka Go, Suzuki Manabu, Kobayashi Konomi, Shiozawa Ayako, Yamamoto Shota, Suzuki Tomoyuki, Sakamoto Keita

Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Session: Mesothelioma and malignant pleural disease
Session type: Poster Discussion
Number: 5085
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eriko Suzuki (Tokyo-to, Japan), Eriko Suzuki, Takeda Yuichiro, Sugiyama Haruhito, Hojo Masayuki, Izumi Shinyu, Ikura Motokazu, Naka Go, Suzuki Manabu, Kobayashi Konomi, Shiozawa Ayako, Yamamoto Shota, Suzuki Tomoyuki, Sakamoto Keita. An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE). Eur Respir J 2016; 48: Suppl. 60, 5085

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Pericardiodesis in pericardial tamponade
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Comparison between bronchoscopy, closed (Abram’s) and medical thoracoscopic pleural biopsies in undiagnosed pleural effusions
Source: International Congress 2016 – Pleural diseases
Year: 2016


Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Solitary fibrous tumour of the pleural: Two malignant cases
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015